2967-93-3

Basic information

• Product Name: Methyl 2-Fluoro-5-Methylbenzoate
• Synonyms: Methyl 2-Fluoro-5-Methylbenzoate;2-FLUORO-5-METHYLBENZOIC ACID METHYL ESTER;Benzoic acid, 2-fluoro-5-methyl-, methyl ester
• CAS NO: 2967-93-3
• Molecular Formula: C₉H₉FO₂
• Molecular Weight: 168.1649632
• Mol File: 2967-93-3.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Methyl 2-Fluoro-5-Methylbenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 2-Fluoro-5-Methylbenzoate(2967-93-3)
• EPA Substance Registry System: Methyl 2-Fluoro-5-Methylbenzoate(2967-93-3)

Safety Data

• Hazardous Substances Data: 2967-93-3(Hazardous Substances Data)

Usage

Chemical Properties

Off-white powder

Upstream product

• 67-56-1 methanol 
• 321-12-0 2-fluoro-5-methyl-benzoic acid 
• 77-78-1 dimethyl sulfate 
• 18595-16-9 2-amino-5-methylbenzoic acid methyl ester 
• 64113-84-4 2-fluoro-5-methylbenzonitrile 

Downstream Products

• 709-45-5 2-fluoro-5-bromomethyl benzoic acid methyl ester 
• 165803-94-1 methyl 2-fluoro-5-formylbenzoate 
• 666857-71-2 6-(dimethylamino)-3-formylbenzoic acid methyl ester 
• 256345-52-5 5-[(3aS,4R,8R,8aS)-4,8-Dibenzyl-2,2-dimethyl-7-(3-nitro-benzyl)-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-2-fluoro-benzoic acid methyl ester 
• 256345-53-6 (3aS,4R,8R,8aS)-4,8-Dibenzyl-5-(3-hydroxy-1H-indazol-5-ylmethyl)-2,2-dimethyl-7-(3-nitro-benzyl)-hexahydro-1,3-dioxa-5,7-diaza-azulen-6-one 
• 256345-54-7 5-[(3aS,4R,8R,8aS)-4,8-Dibenzyl-2,2-dimethyl-7-(3-nitro-benzyl)-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-3-hydroxy-indazole-1-carboxylic acid tert-butyl ester 
• 256345-68-3 5-[(3aS,4R,8R,8aS)-7-(3-Amino-benzyl)-4,8-dibenzyl-2,2-dimethyl-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-3-thiophen-3-yl-indazole-1-carboxylic acid tert-butyl ester 
• 256345-67-2 5-[(3aS,4R,8R,8aS)-7-(3-Amino-benzyl)-4,8-dibenzyl-2,2-dimethyl-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-3-thiophen-2-yl-indazole-1-carboxylic acid tert-butyl ester 
• 256345-57-0 5-[(3aS,4R,8R,8aS)-4,8-Dibenzyl-2,2-dimethyl-7-(3-nitro-benzyl)-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-3-thiophen-2-yl-indazole-1-carboxylic acid tert-butyl ester 
• 256345-58-1 5-[(3aS,4R,8R,8aS)-4,8-Dibenzyl-2,2-dimethyl-7-(3-nitro-benzyl)-6-oxo-hexahydro-1,3-dioxa-5,7-diaza-azulen-5-ylmethyl]-3-thiophen-3-yl-indazole-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

Pyrrolopyrazole derivative and preparation method and medical application thereof

The invention relates to a pyrrolopyrazole derivative and a preparation method and a medical application thereof. Specifically, the invention relates to a new pyrrolopyrazole derivative as shown in ageneral formula (I), a preparation method of the pyrrolopyrazole derivative and application of the pyrrolopyrazole derivative or a pharmaceutical composition containing the pyrrolopyrazole derivativeas a therapeutic agent, particularly as a gastric acid secretion inhibitor and potassium ion competitive acid blockers (P-CABs) in biological medicines, wherein substituents (R1, R2, R3 and R4) and groups (X) in the general formula (I) are the same as defined in the specification.

Discovery of quinazoline-2,4(1: H,3 H)-dione derivatives as novel PARP-1/2 inhibitors: Design, synthesis and their antitumor activity

Novel quinazoline-2,4(1H,3H)-dione derivatives bearing a 3-amino pyrrolidine moiety were designed and synthesized as PARP-1/2 inhibitors. Structure-activity relationships were examined which revealed a number of potent PARP-1/2 inhibitors with moderate se

Design, synthesis and identification of novel colchicine-derived immunosuppressant

Synthesis and biological evaluation of various colchicine analogues through the mixed-lymphocyte reaction (MLR), lymphoproliferation, and inhibitory effects on the inflammatory genes are described. In addition, a new series of immunosuppressive agents developed on the structural basis of colchicine, as well as their structure-activity relationships is reported. The most potent analogue 20a exhibited an excellent immunosuppressive activity on in vivo skin-allograft model, which is comparable to that of cyclosporin A.